Korean Stock Flows

Medy-Tox (KRX: 086900)

메디톡스 KOSDAQ Biotech & Pharma 기초 의약물질 제조업
Close (Oct 16, 2026)
₩67,900
+4.95%
Market cap
₩0T ($0.4B)
52-week range
₩61,600 – ₩141,100
P/E (12M fwd) · P/B · Div yield
14.37 · 1.05 · 1.77%
trailing 28.64 · consensus of 3 analysts

Who is buying Medy-Tox?

Between Sep 15, 2026 and Oct 16, 2026 (20 trading sessions), foreign investors net sold ₩1.5bn ($1M) of Medy-Tox, the 187th largest foreign net sale among 1828 KOSDAQ stocks. Institutions net bought ₩0.2bn ($0M) and retail investors net bought ₩1.1bn ($1M) over the same window. Foreigners were net buyers on 11 of the 20 sessions.

Foreign investors hold 12.14% of Medy-Tox's listed shares (KRX ownership data as of Oct 16, 2026), down from 14.2% twenty sessions earlier and 8.15% a year ago.

The stock closed at ₩67,900 on Oct 16, 2026: -1.31% over 20 sessions, -43.79% year-to-date, -43.32% over one year. The 52-week range is ₩61,600 – ₩141,100.

At ₩67,900 the stock trades at 14.37× 12-month-forward consensus earnings (3 analysts), 13.16× on FY2027 estimates. The trailing P/E published by KRX is 28.64×, based on the last completed fiscal year.

Medy-Tox share price, last 60 trading days (KRW)
81,944 75,448 68,952 62,456 Jul 16 Aug 31 Oct 16
Daily foreign investor net purchases, last 60 trading days
+2.1bn +1bn -1bn -2.1bn Jul 16 Aug 31 Oct 16
View chart data as a table
Date Close Foreign net Institutions Retail
2026-10-16 ₩67,900 +₩1.1bn +₩0.1bn ₩-1.2bn
2026-10-15 ₩64,700 +₩0.4bn +₩0.2bn ₩-0.6bn
2026-10-14 ₩65,800 +₩0.3bn +₩0.2bn ₩-0.5bn
2026-10-13 ₩63,500 +₩0.1bn ₩-0.0bn ₩-0.1bn
2026-10-12 ₩64,100 ₩-0.5bn ₩-0.0bn +₩0.5bn
2026-10-08 ₩65,900 ₩-1.1bn ₩-0.1bn +₩1.1bn
2026-10-07 ₩67,500 +₩0.0bn ₩-0.0bn +₩0.0bn
2026-10-06 ₩67,500 +₩0.1bn +₩0.0bn ₩-0.2bn
2026-10-02 ₩66,600 ₩-0.3bn ₩-0.1bn +₩0.4bn
2026-10-01 ₩67,400 +₩0.1bn +₩0.0bn ₩-0.2bn
2026-09-30 ₩66,500 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-09-29 ₩67,100 ₩-0.7bn ₩-0.0bn +₩0.7bn
2026-09-28 ₩68,700 +₩0.3bn +₩0.1bn ₩-0.4bn
2026-09-23 ₩67,400 ₩-0.1bn ₩-0.0bn +₩0.1bn
2026-09-22 ₩67,300 +₩0.1bn ₩-0.1bn ₩-0.1bn
2026-09-21 ₩68,100 +₩0.0bn ₩-0.0bn +₩0.0bn
2026-09-18 ₩67,300 ₩-1.0bn +₩0.0bn +₩0.9bn
2026-09-17 ₩67,600 ₩-0.2bn ₩-0.0bn +₩0.3bn
2026-09-16 ₩67,800 ₩-0.1bn ₩-0.0bn +₩0.1bn
2026-09-15 ₩68,700 +₩0.1bn ₩-0.0bn ₩-0.1bn
2026-09-14 ₩68,800 ₩-0.1bn ₩-0.1bn +₩0.2bn
2026-09-11 ₩69,600 ₩-0.3bn +₩0.5bn ₩-0.2bn
2026-09-10 ₩69,400 ₩-0.6bn ₩-0.2bn +₩0.7bn
2026-09-09 ₩68,900 ₩-0.7bn +₩0.3bn +₩0.3bn
2026-09-08 ₩69,200 ₩-0.4bn ₩-0.0bn +₩0.4bn
2026-09-07 ₩69,400 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-09-04 ₩69,600 +₩0.1bn +₩0.0bn ₩-0.1bn
2026-09-03 ₩69,300 ₩-1.8bn ₩-0.2bn +₩2.0bn
2026-09-02 ₩71,200 +₩0.0bn ₩-0.1bn +₩0.0bn
2026-09-01 ₩73,000 +₩1.3bn +₩0.1bn ₩-1.3bn
2026-08-31 ₩68,900 ₩-1.1bn +₩0.3bn +₩0.8bn
2026-08-28 ₩71,100 +₩0.8bn +₩0.3bn ₩-1.1bn
2026-08-27 ₩66,900 ₩-1.2bn ₩-0.3bn +₩1.4bn
2026-08-26 ₩68,600 +₩0.6bn ₩-0.2bn ₩-0.4bn
2026-08-25 ₩67,800 ₩-0.3bn ₩-0.0bn +₩0.2bn
2026-08-24 ₩67,400 ₩-0.4bn +₩0.2bn +₩0.2bn
2026-08-21 ₩67,400 ₩-2.1bn ₩-0.2bn +₩2.2bn
2026-08-20 ₩71,000 ₩-0.1bn +₩0.2bn ₩-0.1bn
2026-08-19 ₩68,400 ₩-1.4bn ₩-0.0bn +₩1.4bn
2026-08-18 ₩71,500 ₩-1.9bn ₩-0.2bn +₩2.1bn
2026-08-14 ₩76,900 +₩0.0bn ₩-0.2bn +₩0.2bn
2026-08-13 ₩76,800 +₩0.4bn ₩-0.6bn +₩0.2bn
2026-08-12 ₩77,300 ₩-0.9bn ₩-0.1bn +₩1.0bn
2026-08-11 ₩78,000 ₩-0.5bn +₩0.0bn +₩0.4bn
2026-08-10 ₩80,900 ₩-0.2bn ₩-0.1bn +₩0.3bn
2026-08-07 ₩79,800 +₩0.2bn ₩-0.0bn ₩-0.2bn
2026-08-06 ₩79,000 +₩0.3bn ₩-0.0bn ₩-0.3bn
2026-08-05 ₩76,800 ₩-0.7bn +₩0.1bn +₩0.2bn
2026-08-04 ₩76,900 +₩0.6bn +₩0.1bn ₩-0.6bn
2026-08-03 ₩72,000 +₩0.5bn ₩-0.6bn +₩0.1bn
2026-07-31 ₩72,000 +₩0.1bn ₩-0.0bn ₩-0.1bn
2026-07-30 ₩70,800 +₩0.5bn +₩0.2bn ₩-0.5bn
2026-07-29 ₩68,200 +₩0.2bn +₩0.4bn ₩-0.7bn
2026-07-28 ₩71,300 +₩0.6bn ₩-0.1bn ₩-0.6bn
2026-07-27 ₩73,500 +₩0.2bn +₩0.0bn ₩-0.2bn
2026-07-24 ₩71,000 +₩0.5bn ₩-0.0bn ₩-0.4bn
2026-07-23 ₩71,500 +₩0.5bn +₩0.1bn ₩-0.5bn
2026-07-22 ₩68,300 +₩0.0bn ₩-0.3bn +₩0.3bn
2026-07-21 ₩69,000 +₩0.2bn +₩0.2bn ₩-0.3bn
2026-07-20 ₩68,500 +₩0.1bn ₩-0.3bn +₩0.2bn
2026-07-16 ₩71,600 +₩0.0bn +₩0.3bn ₩-0.2bn

Investor flows summary

Window Foreign (USD) Institutions Retail
1 day +₩1.1bn +$1M +₩0.1bn ₩-1.2bn
5 days +₩1.4bn +$1M +₩0.4bn ₩-1.9bn
20 days ₩-1.5bn $-1M +₩0.2bn +₩1.1bn

Positive = net buying, negative = net selling. Values aggregate the KRX main board and the NXT alternative venue.

Frequently asked questions

Are foreign investors buying Medy-Tox stock?

Over the last 5 sessions foreign investors net bought ₩1.4bn ($1M) of Medy-Tox; over 60 sessions they net sold ₩8.2bn ($6M); since Jan 1, 2026 they net bought ₩15.2bn ($11M). Over 20 sessions the stock is the 187th largest foreign net sale among 1828 KOSDAQ stocks.

How much of Medy-Tox do foreign investors own?

Foreign investors own 12.14% of Medy-Tox's shares as of Oct 16, 2026, versus 8.15% one year earlier. The figure is KRX's daily foreign holdings divided by listed shares, and it reflects trades settled through the previous session.

Who is on the other side — institutions or retail investors?

Over 20 sessions institutions net bought ₩0.2bn ($0M) and retail investors net bought ₩1.1bn ($1M) of Medy-Tox. Foreign selling is being absorbed mainly by retail buying.

Is Medy-Tox listed on KOSPI or KOSDAQ?

Medy-Tox (메디톡스) trades on KOSDAQ under KRX code 086900 in the Biotech & Pharma group, with a market capitalization of ₩0T ($0.4B). Daily net flows by investor type are published by KRX after each session and combine the KRX main board with the NXT venue.

Annual financials

Fiscal year Revenue YoY Operating profit Net income
2023 ₩221bn ($164M) – ₩17bn ($13M) ₩10bn ($7M)
2024 ₩229bn ($170M) +3.40% ₩20bn ($15M) ₩16bn ($12M)
2025 ₩247bn ($184M) +8.20% ₩17bn ($13M) ₩16bn ($12M)

Consolidated (K-IFRS) where available, from DART regulatory filings. USD figures converted at the current rate (₩1345.9/$) for reference only.

← All foreign investor flows